Role of valproate across the ages. Treatment of epilepsy in adults

Acta Neurologica Scandinavica

Volumn 114, Issue SUPPL. 184, 2006, Pages 14-27

  Ben Menachem, E ^a,e   Schmitz, B ^b   Tomson, T ^c   Vajda, F ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adults; Epilepsy; Treatment; Valproate

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; ETHOSUXIMIDE; ETIRACETAM; FOLLITROPIN; GABAPENTIN; LAMOTRIGINE; LUTEINIZING HORMONE; MIRTAZAPINE; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TESTOSTERONE; TIAGABINE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; TERATOGENIC AGENT;

ABSENCE; ADULT; AGGRESSION; AGITATION; ANXIETY DISORDER; APLASTIC ANEMIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CONGENITAL MALFORMATION; CONSENSUS DEVELOPMENT; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MONITORING; DRUG TOLERABILITY; DYSPHORIA; DYSTHYMIA; EPILEPSY; EVIDENCE BASED MEDICINE; FATIGUE; FOCAL EPILEPSY; FOLLITROPIN BLOOD LEVEL; GENERALIZED EPILEPSY; GILLES DE LA TOURETTE SYNDROME; GRAND MAL EPILEPSY; HUMAN; HYPOMANIA; INTELLIGENCE QUOTIENT; LIVER TOXICITY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR DEPRESSION; MENTAL DEFICIENCY; METABOLIC DISORDER; MONOTHERAPY; MOOD DISORDER; MYOCLONUS EPILEPSY; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PARANOIA; PARESTHESIA; PRACTICE GUIDELINE; PRENATAL DRUG EXPOSURE; PSYCHOSIS; QUALITY OF LIFE; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SUICIDE; TERATOGENICITY; TESTOSTERONE BLOOD LEVEL; VISUAL FIELD DEFECT; WEIGHT GAIN; WEST SYNDROME; AGE; CHEMICALLY INDUCED DISORDER; CHILD; DEVELOPMENTAL DISORDER; DRUG EFFECT; FEMALE; FERTILITY; MALE; MENTAL DISEASE; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; ANTICONVULSANTS; CHILD; DEVELOPMENTAL DISABILITIES; EPILEPSY; FEMALE; FERTILITY; HUMANS; MALE; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; TERATOGENS; VALPROIC ACID;

EID: 33745100823     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00667.x     Document Type: Review

References (77)

1. Groupe Carole (Coordination Active du Reseau Observatoire Longitudinal de l'Epilepsie). Treatment of newly diagnosed epileptic crises. A French experience. Rev Neurol 2001 157 : 1500 12.
2. Semah F Picot MC Derambure P et al. The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey. Epileptic Disord 2004 6 : 255 65.
3. Mattson RH Cramer JA Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992 327 : 765 71.
4. Christe W Kramer G Vigonius U et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997 26 : 451 60.
5. Privitera MD Brodie MJ Mattson RH et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003 107 : 165 75.
6. Rowan AJ Meijer JW de Beer-Pawlikowski N van der Geest P Meinardi H. Valproate-ethosuximide combination therapy for refractory absence seizures. Arch Neurol 1983 40 : 797 802.
7. Rosenberry KR Korberly BH Graziani LJ. Combination of clonazepam and sodium valproate in the treatment of refractory epileptic seizures in 12 children. Am J Hosp Pharm 1979 36 : 736 8.
8. Brodie MJ Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 1997 26 : 423 32.
9. Pisani F Oteri G Russo MF Di Perri R Perucca E Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 1999 40 : 1141 6.
10. Messenheimer JA. Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 1998 25 : S14 8.
11. Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 1997 19 : 1294 308.
12. Jallon P Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 2001 24 : 969 78.
13. Bauer J Isojärvi JI Herzog AG et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002 73 : 121 5.
14. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002 16 : 695 714.
15. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993 34 : 588 9.
16. Wide K Winbladh B Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 2004 93 : 174 6.
17. Artama M Auvinen A Raudaskoski T Isojarvi I Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005 64 : 1874 8.
18. Samrén EB van Duijn CM Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997 38 : 981 90.
19. Holmes LB Wyszynski DF Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004 61 : 673 8.
20. Wyszynski DF Nambisan M Surve T et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005 64 : 961 5.
21. Russell AJ Craig JJ Morrison P et al. U.K. epilepsy and pregnancy group. Epilepsia 2004 45 : 1467.
22. Vajda F Lander C O'Brien T et al. Australian Pregnancy Registry of Women taking antiepileptic drugs. Epilepsia 2004 45 : 1466.
23. Cunnington MC. The International Lamotrigine pregnancy registry update for the epilepsy foundation. Epilepsia 2004 45 : 1468.
24. Kaneko S Otani K Hirano T et al. Teratogenicity of antiepileptic drugs: is the prevention possible Jpn Psychiatry Neurol 1991 45 : 478 81.
25. Samrén EB van Duijn CM Christiaens GC Hofman A Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999 46 : 739 46.
26. Canger R Battino D Canevini MP et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999 40 : 1231 6.
27. Adab N Jacoby A Smith D Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001 70 : 15 21.
28. Adab N Kini U Vinten J et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004 75 : 1575 83.
29. Vinten J Adab N Kini U Gorry J Gregg J Baker GA Liverpool and Manchester Neurodevelopment Study Group. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005 64 : 949 54.
30. Gaily E Kantola-Sorsa E Hiilesmaa V et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004 62 : 28 32.
31. Mikkonen K Tapanainen P Pakarinen AJ Paivansalo M Isojarvi JI Vainionpaa LK. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. Epilepsia 2004 45 : 769 76.
32. Isojarvi JI Lofgren E Juntunen KS et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004 62 : 247 53.
33. Bauer J Blumenthal S Reuber M Stoffel-Wagner B. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004 62 : 243 6.
34. Roste LS Tauboll E Morkrid L et al. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Eur J Neurol 2005 12 : 118 24.
35. Rattya J Turkka J Pakarinen AJ et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001 56 : 31 6.
36. Stephen LJ Kwan P Shapiro D Dominiczak M Brodie MJ. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 2001 42 : 1002 6.
37. Pylvanen V Knip M Pakarinen AJ et al. Fasting serum insulin and lipid levels in men with epilepsy. Neurology 2003 60 : 571 4.
38. Kuhn-Velten WN Herzog AG Muller MR. Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis. Eur J Pharmacol 1990 181 : 151 5.
39. Duncan S Blacklaw J Beastall GH Brodie MJ. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 1999 40 : 197 204.
40. Webber MP Hauser WA Ottman R Annegers JF. Fertility in persons with epilepsy: 1935-1974. Epilepsia 1986 27 : 746 52.
41. Schupf N Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994 35 : 750 6.
42. Schupf N Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for reduced fertility in marriage. Epilepsia 1996 37 : 833 40.
43. Dodrill CB Batzel LW. Interictal behavioral features of patients with epilepsy. Epilepsia 1986 27 ( Suppl. 2 S64 76.
44. Jacoby A Baker GA Steen N Potts P Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996 37 : 148 61.
45. Cramer JA Blum D Reed M Fanning K, Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003 4 : 515 21.
46. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002 58 ( Suppl. 5 S9 20.
47. Gilliam F Carter J Vahle V. Tolerability of antiseizure medications: implications for health outcomes. Neurology 2004 63 ( Suppl. 4 S9 12.
48. Blumer D Montouris G Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav 2004 5 : 826 40.
49. Kanner AM Kozak AM Frey M. The use of sertraline in patients with epilepsy: is it safe Epilepsy Behav 2000 1 : 100 5.
50. Matsuura M. Epileptic psychoses and anticonvulsant drug treatment. J Neurol Neurosurg Psychiatry 1999 67 : 231 3.
51. Besag FM. Behavioural effects of the new anticonvulsants. Drug Saf 2001 24 : 513 36.
52. French JA Kanner AM Bautista J et al. Efficacy and tolerability of the new antiepileptic drugs: II. Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004 62 : 1261 73.
53. Levinson DF Devinsky O. Psychiatric adverse events during vigabatrin therapy. Neurology 1999 53 : 1503 11.
54. Sharief M Viteri C Ben-Menachem E et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996 25 : 217 24.
55. Tassinari CA Michelucci R Chauvel P et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996 37 : 763 8.
56. Biton V Montouris GD Ritter F et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999 52 : 1330 7.
57. Trimble MR Rusch N Betts T Crawford PM. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 2000 9 : 249 54.
58. Kanner AM Wuu J Faught E Tatum WO Fix A French JA The PADS Investigators. A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav 2003 4 : 548 52.
59. Mula M Trimble MR Lhatoo SD Sander JW. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003 44 : 659 63.
60. Trimble MR Schmitz B. Forced normalisation and alternative psychoses of epilepsy. Petersfield : Wrightson Biomedical Publishing, 1998.
61. Kanemoto K Tsuji T Kawasaki J. Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification. Epilepsia 2001 42 : 98 103.
62. Schmitz EB Robertson MM Trimble MR. Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res 1999 35 : 59 68.
63. Gajwani P Forsthoff A Muzina D et al. Antiepileptic drugs in mood-disordered patients. Epilepsia 2005 46 ( Suppl. 4 38 44.
64. Van Ameringen M Mancini C Pipe B Bennett M. Antiepileptic drugs in the treatment of anxiety disorders: role in therapy. Drugs 2004 64 : 2199 220.
65. Smith D Baker G Davies G Dewey M Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993 34 : 312 22.
66. Gillham R Baker G Thompson P et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996 24 : 47 55.
67. Edwards KR Sackellares JC Vuong A Hammer AE Barrett PS. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2001 2 : 28 36.
68. Ketter TA Post RM Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999 53 ( Suppl. 2 S53 67.
69. Paradiso S Hermann BP Blumer D Davies K Robinson RG. Impact of depressed mood on neuropsychological status in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2001 70 : 180 5.
70. Gilliam FG Santos J Vahle V Carter J Brown K Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction Epilepsia 2004 45 ( Suppl. 2 28 33.
71. Kaaja E Kaaja R Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003 60 : 575 9.
72. Holmes LB Harvey EA Coull BA et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001 344 : 1132 8.
73. Anthony JC Eaton WW Henderson AS. Looking to the future in psychiatric epidemiology. Epidemiol Rev 1995 17 : 240 2.
74. Barraclough BM. The suicide rate of epilepsy. Acta Psychiatr Scand 1987 76 : 339 45.
75. Kessler RC McGonagle KA Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994 51 : 8 19.
76. Sigurdardottir KR Olafsson E. Incidence of psychogenic seizures in adults: a population-based study in Iceland. Epilepsia 1998 39 : 749 52.
77. Costello EJ. Child psychiatric disorders and their correlates: a primary care pediatric sample. J Am Acad Child Adolesc Psychiatry 1989 28 : 851 5.